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hHR23B is one of two human homologs of the Saccha-
romyces cerevisiae nucleotide excision repair (NER)
gene product RAD23 and a component of a protein com-
plex that specifically complements the NER defect of
xeroderma pigmentosum group C (XP-C) cell extracts in
vitro. Although a small proportion of hHR23B is tightly
complexed with the XP-C responsible gene product, XPC
protein, a vast majority exists as an XPC-free form, in-
dicating that hHR23B has additional functions other
than NER in vivo. Here we demonstrate that the human
NER factor hHR23B as well as another human homolog
of RAD23, hHR23A, interact specifically with S5a, a sub-
unit of the human 26 S proteasome using the yeast two-
hybrid system. Furthermore, hHR23 proteins were de-
tected with S5a at the position where 26 S proteasome
sediments in glycerol gradient centrifugation of HeLa
S100 extracts. Intriguingly, hHR23B showed the inhibi-
tory effect on the degradation of 125I-lysozyme in the
rabbit reticulocyte lysate. hHR23 proteins thus appear
to associate with 26 S proteasome in vivo. From co-pre-
cipitation experiments using several series of deletion
mutants, we defined the domains in hHR23B and S5a
that mediate this interaction. From these results, we
propose that part of hHR23 proteins are involved in the
proteolytic pathway in cells.
We have previously identified two distinct homologs of Sac-
charomyces cerevisiae nucleotide excision repair (NER)1 factor
RAD23, in human as well as in murine cells (1, 2). One of the
human RAD23 homologs, designated hHR23B, was found to be
tightly complexed with the XPC protein that plays an essential
role in a subpathway of human NER operating genome-wide
(1). Although a vast majority of the XPC protein is bound to
hHR23B in vivo, another RAD23 homolog, hHR23A, is also
capable of interacting with XPC at least in vitro. Using recon-
stituted cell-free NER reactions, we further showed that both
hHR23 proteins enhance the repair activity of XPC, suggesting
a possible functional interchangeability between the two
RAD23 homologs (3).
Amino acid sequence comparison of the yeast RAD23 and its
mammalian homologs revealed the existence of at least four
distinct domains which are well conserved among these pro-
teins (Ref. 2, see also upper part of Fig. 4A). First, this class of
proteins is characterized by a Ub-like sequence at the amino
terminus. It was genetically shown that this sequence is im-
portant for the biological function of yeast RAD23 (4). The
second and fourth domains from the amino terminus are ubiq-
uitin-associated domains (5), suggesting a possible involve-
ment of the RAD23 as well as hHR23 proteins in certain path-
ways of ubiquitin metabolism (2). By deletion and truncation
analysis of recombinant hHR23B protein, the third domain has
been recently found to be responsible for binding the XPC
protein (6). These deletion studies also revealed that the iden-
tified XPC-binding domain of hHR23B is necessary and largely
sufficient for the hHR23B NER function in vitro: the Ub-like
sequence and two copies of the ubiquitin-associated domains
appear to be dispensable for the core part of NER. Therefore, it
is conceivable that hHR23B, as well as other members of this
class of proteins, may be associated with ubiquitin metabolic
pathways outside the context of the core NER machinery. In
agreement with this idea, hHR23B exists in vivo in a large
excess over XPC (7, 8), suggesting it has extra functions with-
out XPC.
To explore novel functions of the mammalian RAD23 ho-
mologs, it is of great interest to search for proteins other than
XPC which interact with the hHR23 proteins. For this purpose,
a yeast two-hybrid expression library was screened using
hHR23B as a bait. Here we report the interaction of the hHR23
proteins with a 26 S proteasome subunit, S5a, indicating the
association of the RAD23 homologs with the ubiquitin-depend-
ent protein degradation machinery.
EXPERIMENTAL PROCEDURES
Yeast Two-hybrid Screening—The yeast two-hybrid screening was
performed with the Matchmaker Two-Hybrid System (CLONTECH).
The entire cDNA for hHR23B was fused in-frame with the GAL4
DNA-binding domain in pGBT9 vector (9). The resulting plasmid,
pGBT-hHR23B, was used for transformation of a yeast strain, HF7c,
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and a Trp1 clone was selected. A human cDNA library for the two-
hybrid screening was constructed with TimeSaver cDNA synthesis kit
and Directional cloning toolbox (both from Amersham Pharmacia Bio-
tech). Complementary DNAs were synthesized with NotI/oligo(dT)
primers and poly(A)1 RNA from an SV40-transformed fibroblast cell
line, WI38VA13. After the second strand synthesis, the cDNAs were
ligated to EcoRI adaptors and then digested with NotI, resulting in
double-stranded cDNA fragments bearing EcoRI and NotI overhangs on
the upstream and downstream ends, respectively. The cDNAs were
subsequently cloned into pGAD424 vector encoding the GAL4 activa-
tion domain (9), and introduced into Escherichia coli, DH5a. The plas-
mid DNA was isolated from 7.8 3 107 E. coli colonies. The yeast strain
bearing pGBT-hHR23B was further transformed with the cDNA li-
brary, and positive clones were selected by histidine prototrophs. The
His1 clones were further verified for b-galactosidase activity using a
filter lift assay (10).
Glycerol Gradient Sedimentation Analysis—Cytoplasmic S100 frac-
tion was prepared from HeLa cells as described previously (11). The
HeLa S100 (7 mg of protein) was supplemented with ATP to a final
concentration of 2 mM, and incubated on ice for 1 h. The extract was
overlaid onto a 10–40% glycerol gradient (30 ml) in 25 mM Tris-HCl (pH
7.5), 1 mM dithiothreitol, 2 mM ATP, and subsequently centrifuged at
22,500 rpm (83,000 3 g) for 22 h at 4 °C. One-milliliter fractions were
collected from the bottom of the tube. The proteasome activity of each
fraction (150 ml) was assayed as described previously (12).
Immunoprecipitation—Each of anti-p45 monoclonal antibody and
anti-ubiquitin monoclonal antibody (2C5; MBL Co. Ltd., Japan), were
mixed with Protein G-Sepharose (Amersham Pharmacia Biotech), re-
spectively, in buffer C (20 mM Tris-HCl (pH 7.9), 200 mM EDTA, 20%
glycerol, 0.1 M KCl, 2 mM ATP, 5 mM MgCl2, 0.1% Nonidet P-40, 0.25 mM
PMSF, 10 mM 2-mercaptoethanol) containing 200 mg/ml bovine serum
albumin at 4 °C for 30 min with rotation. The beads were then washed
three times with buffer C. The antibody bound-Sepharose beads (5 ml)
were incubated with 150 mg of whole cell extract prepared from HeLa
cells (13) in 80 ml of buffer C at 4 °C for 1 h with rotation. The mixture
was centrifuged, and the precipitates were washed three times with
buffer C. The bound proteins were extracted by boiling in SDS sample
buffer, separated by 8% SDS-PAGE, and analyzed by immunoblotting
with anti-hHR23B and anti-XPC antibody.
Preparation of Recombinant hHR23, S5a, and NEDD8 Proteins—
Recombinant hHR23A and hHR23B proteins (designated as rhHR23A
and rhHR23B) as well as a series of deletion mutants of hHR23B were
expressed in E. coli and purified as described previously (6). Ub-
rhHR23B, which has the ubiquitin sequence instead of the original
Ub-like sequence on its NH2 terminus, was constructed. Ubiquitin
cDNA was obtained from a human cDNA library using polymerase
chain reaction technique, and inserted in-frame into pET-24d (Nova-
gen) which harbors hHR23B with an NH2-terminal deletion encoding
amino acids 73–409 (6). The resulting plasmid expresses hHR23B with
the ubiquitin sequence on its NH2 terminus instead of the Ub-like
domain in E. coli. The expression and purification of the protein was
performed as described previously (6). Recombinant human S5a (des-
ignated as rS5a) protein was expressed in E. coli BL21(DE3) using
pET3a vector (Novagen). Cells containing the S5a construct were grown
at 30 °C, induced with 1 mM isopropyl-b-D-thiogalactopyranoside for
3 h, collected by centrifugation of approximately 1 liter of culture,
washed with 50 mM Tris-HCl (pH 7.5) containing 10% glycerol, and
suspended in 20 mM sodium phosphate (pH 6.8), 0.3 M NaCl, 0.25 mM
PMSF. The suspension was incubated on ice for 15 min with 1 mg of
lysozyme/ml, frozen in liquid nitrogen, and thawed at 4 °C. The lysate
was adjusted to 35% saturation of ammonium sulfate (0.164 g of solid/
ml). The precipitates were collected by centrifugation (20,000 3 g, 30
min), dissolved in 20 mM sodium phosphate (pH 6.8) containing 0.25 mM
PMSF and then dialyzed against 20 mM sodium phosphate (pH 6.8)
containing 0.8 M ammonium sulfate. After removal of insoluble mate-
rials by centrifugation, the dialysate was loaded on a 1-ml butyl-Sepha-
rose 4FF column (Amersham Pharmacia Biotech) equilibrated with 20
mM sodium phosphate (pH 6.8) containing 0.8 M ammonium sulfate.
The column was washed with the same buffer and bound proteins were
eluted with 40 ml of a decreasing ammonium sulfate gradient from 0.8
to 0 M. rS5a, detected by SDS-PAGE and Coomassie Brilliant Blue
staining, was eluted during the last part of the gradient. The fractions
containing rS5a were pooled. After the dialysis against 20 mM sodium
phosphate (pH 6.8) containing 0.25 mM PMSF, the dialysate was loaded
on a 1-ml Hi-Trap Q-Sepharose column (Amersham Pharmacia Biotech)
equilibrated with the same buffer. After the column was washed with
an excess amount of the same buffer, bound proteins were eluted with
20 mM sodium phosphate (pH 6.8), 0.25 mM PMSF, 1 M NaCl. The peak
fractions of rS5a were stored at 280 °C. S5a was also expressed as
6His- or GST-tagged versions using 6HisT-pET11d or pGEX-2T(1)
vector, respectively. The tagged rS5a proteins were purified by nickel-
chelating Sepharose (for 6His-tagged proteins) or glutathione-Sepha-
rose (Amersham Pharmacia Biotech) column chromatography (for GST-
tagged proteins). For generation of various types of S5a deletion
mutants, 59 primers were designed with NdeI restriction sites at se-
lected internal methionine codons. 39 Primers containing EcoRI restric-
tion sites were also designed to generate COOH-terminal deletion mu-
tants. The polymerase chain reaction products were inserted into
6HisT-pET11d vector for expression. A series of deletion mutants of S5a
was expressed and purified as described above. NEDD8 (14) was ex-
pressed as 6His-tagged version using pET24a vector. The tagged
NEDD8 (rNEDD8–6His) protein was purified as described above.
Protein Degradation Assay—Lysozyme was iodinated with Na125I
using Iodo-Beads (Pierce) according to the manufacture’s instruction.
Assay of 125I-lysozyme degradation was performed by the procedure
described previously (15) with the following modifications. Briefly, 40 ml
of the rabbit reticulocyte extracts were incubated for 30 min at 37 °C in
a total volume of 100 ml which contained 50 mM Tris-HCl (pH 7.5), 5 mM
MgCl2, 1 mM dithiothreitol, and either an ATP-regenerating system (2
mM ATP, 10 mg/ml creatin phosphokinase, 10 mM phosphocreatin) or
ATP-depleting system (1 mg/ml hexokinase, 10 mM glucose) prior to
adding 125I-lysozyme (20,000 cpm). After incubation for 1 h at 37 °C, the
reaction was terminated by addition of 575 ml of 10% trichloroacetic
acid with 125 ml of 4% of bovine serum albumin as a carrier. Radioac-
tivity in the supernatants and the precipitated pellets were counted by
g spectrophotometry (WALLAC, WIZARD 1840). To assess the effect of
S5a or hHR23B on the 125I-lysozyme degradation, each recombinant
proteins were incubated with reticulocyte extracts for 30 min on ice
before the addition of 125I-lysozyme. In experiments designed to dem-
onstrate the stability of rhHR23B-6His, rhHR23B-6His was incubated
at 37 °C for 1 h in reticulocyte extracts and collected by nickel-chelating
Sepharose beads as described above. Then, the collected proteins were
subjected to 12% SDS-PAGE, and detected by monoclonal antibody
raised against pentahistidine (QIAGEN).
In Vitro Binding Assay—The rhHR23B-6His (full-length, truncated,
or Ub-fused) proteins (30 pmol) or the rNEDD8–6His protein (30 pmol)
were incubated with non-tagged rS5a protein (3 pmol) in buffer H (20
mM HEPES (pH 7.9), 0.1 M NaCl, 20% glycerol, 0.1% Nonidet P-40, 200
mg/ml bovine serum albumin, 0.25 mM PMSF, 10 mM 2-mercaptoetha-
nol) on ice for 1 h. Each protein sample was mixed with a 2-fold volume
of a suspension of nickel-chelating Sepharose beads in buffer H con-
taining 20 mM imidazole, and incubated for 1 h at 4 °C. The mixture was
centrifuged, and the beads were washed three times with buffer H
containing 60 mM imidazole. The bound proteins were extracted by
boiling in SDS sample buffer, separated by 10% SDS-PAGE, and ana-
lyzed by immunoblotting with anti-S5a antibody. The in vitro binding
assay for a series of 6His-tagged rS5a mutants (30 pmol) with either
non-tagged rhHR23A or rhHR23B (3 pmol) was performed as described
above except that either anti-hHR23A or anti-hHR23B antibody was
used for immunoblotting.
Competition Assay—The rhHR23B-6His protein (3 pmol) was mixed
with various amounts of competitor in 100 ml of buffer H, and then
incubated with GST-rS5a (15 pmol) on ice for 1 h. Both the rhHR23B-
(1–87) protein (containing the NH2-terminal Ub-like portion of
hHR23B) and the ubiquitin molecule were used as competitor. Then
glutathione-Sepharose beads were added and mixed at 4 °C overnight.
The mixture was centrifuged, and the resin was washed with buffer H.
The bound proteins were extracted by boiling in SDS sample buffer,
separated by 10% SDS-PAGE, and analyzed by immunoblotting with
anti-hHR23B antibody.
Antibodies—Antibodies against hHR23B, hHR23A, and XPC were
obtained as described previously (7). Anti-S5a antibody was obtained by
immunization of rabbits with a 6His-tagged rS5a, and purified with
affinity chromatography at MBL Co. Ltd. The serum of anti-p45 mono-
clonal antibody was kindly provided by Klavs B. Hendil.
Other Methods—SDS-PAGE was performed as described by Laemmli
(16). For the immunoblotting, proteins separated on SDS gels were
electrotransferred onto polyvinylidene difluoride membrane (Immo-
bilon-P; Millipore), at 8 V/cm overnight in ice-cold transfer buffer (50
mM Tris, 38.4 mM glycine, 0.01% SDS, 15% methanol). The membranes
were successively incubated in blocking buffer (5% skim milk in 25 mM
Tris-HCl (pH 7.5), 0.15 M NaCl, 0.1% Tween 20), with first antibody in
blocking buffer, and then with anti-rabbit or anti-mouse F(ab9)2 anti-
body conjugated with horseradish peroxidase (Amersham Pharmacia
Biotech) in blocking buffer. Detection was carried out with SuperSignal
Substrate (Pierce) according to the manufactures instructions. Protein
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concentration was measured according to the method of Bradford (17),
using Bio-Rad Protein Assay reagent (Bio-Rad Laboratories) and bovine
serum albumin as a standard.
RESULTS
hHR23B Interacts with S5a, a Component of the Human 26 S
Proteasome Regulatory Subunit—To isolate proteins which in-
teract with hHR23B, we performed a yeast two-hybrid screen-
ing. The interaction of the hHR23B fusion protein with its
known partner, XPC, was confirmed both by histidine proto-
trophy conferred on the yeast strain and by an intense blue
color upon in situ b-galactosidase assay (Table I, line 4). These
results indicate that hHR23B was expressed and interacted
specifically with a known natural target molecule in yeast as
reported previously (18). The screening of 1.5 3 107 yeast
transformants yielded 20 candidate His1 and LacZ1 clones, 17
of which contain cDNA encoding the human S5a protein, one of
the regulatory subunits of 26 S proteasome (19). One clone
covers full-length of the S5a cDNA, the others encode S5a with
NH2-terminal truncation of various size, suggesting that the
COOH-terminal part of S5a may be responsible for interaction
with hHR23B. To confirm the specificity of the observed inter-
action, pGAD plasmids were isolated from several clones, and
reintroduced into yeast in combination of pGBT-hHR23B. As
expected, the histidine prototrophy and b-galactosidase activ-
ity were observed in yeast expressing both S5a protein and
hHR23B (Table I, lines 6–9). It should be noted that the inter-
action of truncated S5a with hHR23B was stronger (lines 7–9)
than that of intact S5a (line 6) as determined in the b-galacto-
sidase assay (see “Discussion”). Furthermore, another human
homolog of RAD23, hHR23A, was also found to interact with
S5a (Table I, line 11). S5a is known as a multiubiquitin chain-
binding protein. Since both hHR23 proteins have highly con-
served Ub-related sequences on NH2 termini (1, 2), we specu-
lated that these sequences are involved in the interaction with
S5a.
hHR23B Interacts with 26 S Proteasome in Cell Extracts—
The above results of a yeast two-hybrid screening showed that
hHR23 proteins interact with S5a, suggesting that hHR23
proteins might be able to associate with 26 S proteasome via
the interaction with S5a in vivo. Such an association can be
analyzed by immunoblot analysis of fractions of cell extracts
separated through glycerol gradient centrifugation after prein-
cubation of the extracts in the presence of 2 mM ATP, which
promotes assembly of 26 S proteasome in cell extracts (20).
Thus, identification of putative subunits of the proteasome can
be determined by analysis of their distribution over the gradi-
ent. When the distribution of hHR23B was analyzed, the pro-
tein was found to migrate with S5a peaking at fraction 9 (Fig.
1A), although the vast majority of hHR23B was found in slower
sedimenting fractions (Fig. 1A). Under these conditions, most
of the 26 S proteasome activity was observed in fraction 9 (Fig.
1B). Similar results were obtained in the case of hHR23A
experiments (data not shown). We previously reported that the
sedimentation coefficient of the XPC-hHR23B complex is 6.2 S
(1). Furthermore, in the absence of ATP, hHR23 proteins were
sedimented with 19 S regulatory complex through glycerol
gradient centrifugation (data not shown). To explore the asso-
ciation between hHR23 proteins and 26 S proteasome in a
different way, HeLa whole cell extracts were used for immuno-
precipitation with monoclonal antibody raised against p45, one
of the regulatory components of 26 S proteasome (21). Fig. 2
indicates that a part of hHR23B associates with the protea-
some regulatory complex containing S5a in the cell extracts,
although co-precipitation of XPC was undetected. These results
strengthened our hypothesis that hHR23 proteins are associ-
ated with 26 S proteasome at least through the interaction with
S5a in cell extracts.
FIG. 1. Co-fractionation of hHR23 proteins with the 26 S pro-
teasome through glycerol density sedimentation. HeLa S100 was
sedimented on a 10–40% glycerol density gradient by centrifugation in
the presence of 2 mM ATP, and fractions were collected. A, the distri-
bution of hHR23B and S5a was assessed by immunoblotting. Proteins
(present in 150 ml of each fraction) were precipitated with cold acetone
and subjected to immunoblot analysis. fr., fraction; I, 10% input. B,
Measurement of the proteasome activity. S values are indicated with
arrowhead. The open squares represent the proteasome activity in the
absence of 0.02% SDS. Closed circles represent the proteasome activity
in the presence of 0.02% SDS. Numbers at the bottom of panel B
correspond to the fraction numbers of panel A.
TABLE I
Protein-protein interactions assessed by the yeast two-hybrid system
Yeast strain, HF7c, was transformed with the pGBT9 bait and pGAD424 target expression vectors.
Bait construct Target construct Histidine prototropha b-Galactosidase assaya
1. pGBT9 only pGAD424 only 2 2
2. pGBT9-hHR23B pGAD424 only 2 2
3. pGBT9 only pGAD424-XPC 2 2
4. pGBT9-hHR23B pGAD424-XPC 1 1
5. pGBT9 only pGAD424-S5a 2 NDb
6. pGBT9-hHR23B pGAD424-S5a 1 1
7. pGBT9-hHR23B pGAD424-S5a114–377 1 11
8. pGBT9-hHR23B pGAD424-S5a184–377 1 11
9. pGBT9-hHR23B pGAD424-S5a192–377 1 11
10. pGBT9-hHR23A pGAD424 only 2 ND
11. pGBT9-hHR23A pGAD424-S5a 1 ND
a 2, no evidence for histidine prototrophy and color change of the yeast colony; 1 and/or 11, histidine prototrophy or intensity color.
b ND, not determined.
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Inhibition of Lysozyme Degradation by hHR23B—To explore
the physiological meaning of the interaction between hHR23
proteins and 26 S proteasome, the effects of hHR23B on 125I-
lysozyme degradation was demonstrated using rabbit reticulo-
cyte extracts. It was previously reported that the Arabidopsis
S5a inhibits the degradation of multiubiquitinated lysozyme in
reticulocyte extract (22). As shown in Fig. 3A, human S5a was
sufficient to interrupt 125I-lysozyme degradation in reticulocyte
extracts as well (lane 2). Intriguingly, 125I-lysozyme degrada-
tion was also inhibited by the addition of rhHR23B-6His in a
dose-dependent manner (lanes 3–6). It is possible that
rhHR23B-6His works as a competitor for 125I-lysozyme degra-
dation by proteasome in reticulocyte extracts, because hHR23
proteins are associated with the S5a subunit of 26 S protea-
some as described above. Surprisingly, no proteolysis of
rhHR23B-6His was observed during a 3-h incubation (Fig. 3B).
These data indicate that the physiological relation lies between
hHR23B and 26 S proteasome. It has been generally accepted
that protein substrate for the ubiquitin-dependent proteolysis
would be multiubiquitinated by ubiquitination and degraded
by 26 S proteasome in rabbit reticulocyte extracts. It is likely,
therefore, that the Ub-like domain of the hHR23 proteins is
very competitive with multiubiquitin chain.
Determination of the S5a-binding Domain in hHR23B—To
further explore the meaning of the interaction between hHR23
proteins and S5a, several experiments were performed using
recombinant S5a (rS5a) expressed in E. coli. We previously
identified the region in hHR23B that affects the interaction
with XPC using 6His-tagged recombinant hHR23B (rhHR23B-
6His) proteins with various deletion mutant (6). These mutant
proteins were used to identify the region responsible for the
interaction with S5a. Mutant rhHR23B-6His proteins, summa-
rized in Fig. 4A, were adsorbed to nickel-chelating Sepharose
beads, and then incubated with non-tagged rS5a protein. Co-
precipitation of S5a was assessed by immunoblotting. As
shown in Fig. 4B, rhHR23B lacking 72 amino acids from the
NH2 terminus failed to interact with S5a (lane 3), whereas the
polypeptide corresponding to only 87 amino acids from the NH2
terminus of hHR23B, designated as rhHR23B-(1–87), was suf-
ficient to precipitate the S5a molecule (lane 12). As we reported
previously, the NH2-terminal region (amino acids 1 to 79) in
hHR23B shares a homology to ubiquitin (1). Identification of
the Ub-like sequence as the S5a-interacting domain of hHR23B
raised the possibility that the S5a protein binds to any proteins
FIG. 2. Co-immunoprecipitation of 26 S proteasome and
hHR23B from HeLa whole cell extract. Antibody bound-Sepharose
beads were incubated with HeLa whole cell extract in buffer C at 4 °C
for 1 h with rotation. Bound proteins were separated by 8% SDS-PAGE.
10% input of HeLa whole cell extract is shown in lane 1. Anti-ubiquitin
antibody (anti-Ub) served as a negative control (lane 2). To precipitate
the proteasome complex, anti-p45 antibody (anti-p45) was used (lane 3).
XPC, a known partner of hHR23B, and hHR23B were assessed
by immunoblotting using anti-XPC or anti-hHR23B antibodies,
respectively.
FIG. 3. Inhibition of 125I-lysozyme degradation by rhHR23B-
6His. A, 125I-lysozyme was incubated with rabbit reticulocyte extracts
at 37 °C for 1 h. Proteolysis of 125I-lysozyme was measured in the
presence of either rhS5a or rhHR23B-6His. Lane 1 shows the ATP-de-
pendent 125I-lysozyme degradation. Relative degradation of 125I-ly-
sozyme in the presence of rhS5a (20 mg) was shown in lane 2, and in the
presence of rhHR23B-6His (1, 5, 20, and 30 mg) was shown in lanes 3–6,
respectively. Each value was the mean 6 S.D. of at least three inde-
pendent experiments. B, the stability of rhHR23B-6His (20 mg) in the
rabbit reticulocyte lysate was assessed. After incubation at 37 °C for the
indicated time above each lane, the materials bound to the nickel-
chelating Sepharose beads were recovered. The presence of precipitated
hexahistidine-tagged protein was detected by immunoblotting using
anti-pentahistidine antibody. Closed arrowhead indicates the intact
rhHR23B-6His protein. Molecular weight was indicated on the left side
of the panel.
FIG. 4. S5a binding activities of truncated rhHR23B-6His pro-
teins. A, summary of the mutant 6His-tagged rhHR23B (rhHR23B-
6His) proteins. Ubiquitin, ubiquitin-like region; SPTA-rich, four kinds
of related amino acids (S, P, T, and A) are predominant in this region;
UBA, ubiquitin-associated domain; XPC-binding, XPC-binding domain;
aa, amino acids. B, the presence of precipitated rS5a was assessed by
immunoblotting. 10% input of rS5a is shown in lane 1. The proteins
bound to the nickel-chelating Sepharose beads are shown in lanes 2–13.
Lane 2 is a negative control (no hHR23B protein) and lanes 3–13
correspond to lane numbers in panel A.
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which are conjugated with ubiquitin. To examine whether this
is the case, we performed competition experiments using either
free ubiquitin itself or the NH2-terminal Ub-like domain of
hHR23B. As shown in Fig. 5, hHR23B was detected in the
precipitate fraction with GST-rS5a and glutathione-Sepharose
beads (lane 3). Interestingly, the amount of precipitated
hHR23B by GST-rS5a was dramatically decreased by the ad-
dition of rhHR23B-(1–87) in a concentration-dependent man-
ner (Fig. 5, lanes 4–6), while the same concentration of ubiq-
uitin monomer only slightly affected the interaction between
GST-rS5a and rhHR23B (Fig. 5, lanes 7–9). One might argue
that the S5a protein efficiently binds both Ub-like domains and
ubiquitin itself only when fused to other proteins, via the
COOH terminus, because the hHR23B-(1–87) has extra 8
amino acids beyond the Ub-like domain. To test this hypothe-
sis, we prepared a chimeric protein, in which the Ub-like in
hHR23B was replaced by ubiquitin itself (Ub-rhHR23B-6His).
S5a was incubated with either rhHR23B-6His or Ub-rhHR23B-
6His and pulled down with nickel-chelating Sepharose beads.
As shown in Fig. 6A, S5a was hardly co-precipitated with
Ub-rhHR23B-6His (lane 3), while rhHR23B-6His efficiently
binds S5a (lane 4). To further confirm the specificity of the
interaction between hHR23B and S5a, another binding exper-
iment was performed using one of the Ub-like proteins, NEDD8
(14). NEDD8 shows high homology to ubiquitin (81 amino acids
which show 58% identity and 79% similarity with ubiquitin),
but its role in proteolysis has not been identified. Fig. 6B shows
the specific interaction between hHR23B and S5a (lane 4) but
not between NEDD8 and S5a (lane 3). These results indicate
that the Ub-like domain of hHR23B is necessary and sufficient
to interact with S5a, and establish the specificity of S5a for
binding to the Ub-like sequence.
Determination of the hHR23-binding Domain in S5a—To
localize the region in S5a that mediates the interaction with
both hHR23 proteins, a series of truncated S5a proteins was
also prepared (Fig. 7A). Amino acid sequence comparison
among the S5a homologs in eukaryotes revealed a highly con-
served region in the COOH-terminal half, which contains some
hydrophobic amino acids (23). To examine binding to both
hHR23 proteins, the 6His-tagged rS5a (full-length or trun-
cated) proteins were incubated with either non-tagged
rhHR23B or rhHR23A. The tagged proteins were pulled down
with nickel-chelating Sepharose beads, and the presence of
both rhHR23 proteins in the precipitate fractions was assessed
by immunoblotting. As shown in Fig. 7, the rhHR23 proteins
itself did not bind nickel-chelating Sepharose beads (Fig. 7,
panels B and C, lane 2). In the presence of the full-length
6His-tagged rS5a, detectable amounts of both rhHR23 proteins
were precipitated (Fig. 7, panels B and C, lane 3), indicating
that not only hHR23B but also hHR23A formed a physical
complex with rS5a in vitro as expected from the two-hybrid
assay. When no more than 262 amino acids were deleted from
the NH2 terminus, both hHR23 proteins were still bound to the
mutant rS5a proteins (Fig. 7, panels B and C, lanes 4–6). As for
the deletion from the COOH terminus, both hHR23 proteins
were detected in the bound fractions with the 6His-tagged rS5a
lacking amino acids from residue Gly344 onwards to the COOH
terminus (Fig. 7, panels B and C, lane 7). However, further
deletion toward the NH2 terminus abolished the hHR23 bind-
ing activities almost completely (Fig. 7, panels B and C, lanes 8
and 9). These results indicate that the hHR23-binding domain
is located within the region covering amino acids Met263 to
Pro343 of S5a (Fig. 8A). To further define the region for hHR23-
binding in S5a, another series of mutant S5a proteins were
subjected to the binding assay (Fig. 8A). Fig. 8 (panels B and C)
shows that polypeptide corresponding to amino acid 263–307 of
S5a efficiently binds both hHR23B and hHR23A (lane 6). More-
over, amino acids from Met263 to Met281 are necessary for the
binding (Fig. 8, B and C, lanes 3 and 4).
DISCUSSION
RAD23 was originally isolated in a screening for ultraviolet-
sensitive mutants (24) and was the first Ub-like protein iden-
tified in yeast (4). The Ub-like sequence of RAD23 was shown to
be important for its NER function in yeast. However, a require-
ment for the Ub-like sequence in hHR23B is not clear at least
in the cell-free NER system (6). Previously, we have examined
the interaction of hHR23B and XPC proteins by using several
deletion mutants of hHR23B protein. The XPC-binding domain
was mapped near the COOH terminus of hHR23B, to a region
FIG. 5. Effects of hHR23B-(1–87) and ubiquitin on the interac-
tion between rhHR23B and rS5a. A, rhHR23B-6His (3 pmol) and
GST-rS5a (15 pmol) were mixed, and the materials bound to glutathi-
one-Sepharose beads were recovered as described under “Experimental
Procedures.” Bound proteins to glutathione-Sepharose beads are shown
in lanes 2–9. 50% input of GST-rS5a and 20% input of rhHR23B-6His
are shown in lane 1. Either rhHR23B-(1–87) or ubiquitin was used as a
competitor with the indicated amount above each lane. B, graphical
representation of the results of panel A, presented as the percentage of
recovered rhHR23B-6His without competitor. The signals of panel A
were quantified using NIH Image software. For proper comparison, the
quantified amount of hHR23B was normalized to the amount of the
recovered S5a. The solid bar represents the recovered hHR23B without
any competitor. The striped bars represent the amount of hHR23B in
the presence of hHR23B-(1–87). The gray bars represent the amount of
hHR23B in the presence of ubiquitin. The numbers at the bottom
correspond to the lane numbers in panel A.
FIG. 6. S5a binding activity of Ub-rhHR23B-6His. rS5a was
mixed with either Ub-rhHR23B-6His or rhHR23B-6His in buffer H at
4 °C for 1 h, and the materials bound to the nickel-chelating Sepharose
beads were recovered. Bound proteins to the nickel-chelating Sepharose
beads without protein (lane 2), with Ub-rhHR23B-6His (panel A, lane 3)
or rNEDD8–6His (panel B, lane 3), and with rhHR23B-6His (lane 4)
are shown. A and B, 20% input of rS5a is shown in lane 1. The presence
of precipitated rS5a was assessed by immunoblotting using anti-S5a
antibody.
Interaction of hHR23 Proteins with S5a 28023
 at Erasm
us M
C M
edical Library on O
ctober 23, 2006 
w
w
w
.jbc.org
D
ow
nloaded from
 
with a putative amphipathic helical character but the NH2-
terminal Ub-like sequence was not absolutely required for the
interaction. Therefore, it is unlikely that the Ub-like sequence
plays a crucial role in complex formation between XPC and
hHR23B. Furthermore, the majority of hHR23 proteins are free
from XPC in human cells (7, 8). These results strongly suggest
that the hHR23 proteins have an additional role in cells other
than the complex formation with XPC.
Physiological Interaction between hHR23B and 26 S Protea-
some—Here we described the physical association between
hHR23 proteins and S5a, one of the regulatory subunits of 26 S
proteasome, using a yeast two-hybrid system. Furthermore, we
report here that hHR23B associates with 26 S proteasome by
both the glycerol gradient sedimentation and co-immunopre-
cipitation (Figs. 1 and 2). As shown in the yeast two-hybrid
experiment, the interaction of NH2-terminal-truncated S5a
with hHR23B was stronger than that of intact S5a (Table, lines
6–9). This finding can be explained in two ways. One is that the
NH2-terminal portion of S5a reduces the interaction of S5a
with hHR23B. The other is that the deletion mutants have a
better conformation to interact with hHR23B than the full-
length S5a when expressed as a fusion protein with GAL4
DNA-binding domain. Recently, it was reported that RAD23
interacts with yeast 26 S proteasome at least through Cim5, an
ATPase subunit, via its NH2-terminal portion (25), whereas
Mcb1, an yeast counterpart of human S5a, has not been proven
to interact with RAD23. It was also reported that hemaggluti-
nin-tagged RAD23 is rapidly degraded in a 26 S proteasome-
dependent manner in yeast (25). These data raise the possibil-
ity that the hHR23 proteins migrate with 26 S proteasome to be
degraded as same as in yeast. However, our results propose the
different possibility. We demonstrated here that hHR23B in-
hibited the lysozyme degradation in reticulocyte extracts with-
out its own degradation (Fig. 3). This stability of hHR23B
supports the previous finding that the native RAD23 protein is
extremely stable, and Ub-like domain in RAD23 does not me-
diate its degradation in yeast (4). Thus we propose the model
that hHR23B somehow regulates the proteolysis of the ubiq-
uitinated protein by 26 S proteasome via the specific interac-
tion with S5a, rather than 26 S proteasome simply degrades
hHR23 proteins as its target.
The Ub-like Domain of hHR23 Proteins and the Multiubiq-
uitin Chain-binding Domain of S5a Are Responsible for Inter-
action between hHR23 Proteins and S5a—We demonstrated
that the Ub-like domain of hHR23B is necessary to interact
directly with S5a (Fig. 4B, lanes 4 and 13). This result corre-
sponds well with the previous finding that the Ub-like domain
of hHR23B is sufficient to interact with 26 S proteasome in
HeLa cell extracts (25). Our present paper is the first report to
indicate clearly that one of the hHR23-interacting protein in
the 26 S proteasome is S5a in mammalian cells. While
rhHR23B-(1–87) protein has extra sequences (8 amino acids)
beyond the Ub-like domain, we obtained evidence that the first
72 amino acids (which show 32% identity and 58% similarity
with ubiquitin) are responsible for the binding with the mul-
tiubiquitin chain binding protein S5a (see Fig. 4B, lane 4). It is
obvious from the previous report by van Nocker et al. (26) as
well as our present data that S5a has only a poor affinity to the
ubiquitin monomer. On the other hand, we previously reported
that the majority of hHR23 proteins exist as a monomer form in
cell extracts (3). Our present results indicate that the Ub-like
domain of the hHR23 proteins has a high affinity for S5a as a
monomer (Figs. 5 and 6A). In contrast to this, neither Ub-
rhHR23B nor NEDD8, which shows high homology to ubiq-
uitin, can interact with S5a (Fig. 6). These results strongly
suggest that S5a has a high preference for binding to the
Ub-like domain of hHR23 proteins. Watkins et al. (4), however,
FIG. 7. Binding of rhHR23 proteins to truncated 6His-tagged
rS5a. A, a summary of the mutant 6His-tagged rS5a proteins. The gray
bar represents the binding domain for the hHR23 proteins. GVDP
repeat, region which includes the GVDP tetrapeptide highly conserved
among S5a homologs; aa, amino acids. B and C, the presence of precip-
itated rhHR23B (panel B) and rhHR23A (panel C) was assessed by
immunoblotting. 20% input of rhHR23B (panel B) and rhHR23A (panel
C) is shown in each lane 1. The proteins bound to the nickel-chelating
Sepharose beads are shown in lanes 2–9. Lane 2 is a negative control (no
S5a protein), and lanes 3–9 correspond to lane numbers in panel A.
FIG. 8. Further analysis of the S5a region binding to the
hHR23 proteins. A, summary of the mutant 6His-tagged rS5a pro-
teins. The amino acid sequence of S5a263–307 is presented in the
one-letter amino acid code. IAYAM, five hydrophobic amino acids which
are highly conserved in S5a homologs; aa, amino acids. B and C, the
presence of precipitated rhHR23B (panel B) and rhHR23A (panel C)
was assessed by immunoblotting. 20% input of rhHR23B (panel B) and
rhHR23A (panel C) is shown in each lane 1. The proteins bound to the
nickel-chelating Sepharose beads are shown in lanes 2–6. Lane 2 is a
negative control (no S5a protein) and lanes 3–6 correspond to lane
numbers in panel A.
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previously reported that Ub-RAD23 can functionally replace
the UV damage response of the native RAD23 protein in
yeast. Therefore, it is also likely that Ub-hHR23B is able to
substitute the physiological function of native hHR23B in
human cell. In addition we mapped the hHR23-binding re-
gion in S5a. So far, the S5a homolog has been isolated from S.
cerevisiae, Arabidopsis, Drosophila, mouse, and human (23,
26–30), and several lines of evidence have been obtained that
S5a is a multiubiquitin chain-binding protein. Based on
amino acid sequence alignments, it was noted that S5a ho-
mologs harbor a highly conserved sequence starting from the
specific tetrapeptide, GVDP (23). Two repeats of this se-
quence were identified in higher eukaryotic proteins, while
the S. cerevisiae S5a homolog has only one. The hHR23-
binding region comprised of 81 amino acids was mapped
between the GVDP tetrapeptide repeats in S5a (Fig. 7). Re-
cently, three independent groups reported the identification
of the multiubiquitin chain-binding site in S5a homologs
(31–33). Especially, two multiubiquitin-binding sites were
identified in human S5a, designated as PUbS1 (Met196-
Ala241) and PUbS2 (Met263-Asp307) (33). PUbS1 has a GVDP
tetrapeptide and a conserved hydrophobic amino acid stretch.
PUbS2 lacks the GVDP tetrapeptide but has a hydrophobic
amino acid stretch which is also conserved among higher
eukaryotes. PUbS2 was shown to exhibit higher affinity for
multiubiquitin chain compare with PUbS1 (33). Surprisingly,
the region responsible for the interaction with hHR23 pro-
teins in S5a is identical to the sequence of PUbS2 (Fig. 8A).
These results indicate that a monomer of the Ub-like domain
of hHR23B is able to bind to the multiubiquitin chain-binding
region of S5a and support our hypothesis that hHR23 pro-
teins might be competitive with multiubiquitin chain. Our
experiments using a series of deletion mutants of hHR23-
binding domain of S5a indicate further that the stretch of
amino acids NH2-terminal to the hydrophobic region
(IAYAM) are necessary for binding activity (Fig. 8, B and C,
lanes 4 and 5). It was reported that the presence of amino
acids NH2-terminal to the hydrophobic region increased the
amount of multiubiquitin chain bound for PUbS2 (33). These
results thus indicate that the site for hHR23-binding over-
laps with the site for multiubiquitin-binding in S5a. How-
ever, it remains to be determined whether the amino acids
NH2-terminal to the hydrophobic region of S5a are sufficient
to interact with the hHR23 proteins, and whether hHR23
proteins and the ubiquitin polymer could compete with each
other for binding to S5a. These issues are now under inves-
tigation in our laboratory.
It is well known that DNA damage causes a significant
problem for eukaryotic cells (34). To facilitate repair processes
prior to DNA replication and cell division, the cell cycle is
rigidly controlled in response to DNA damage. Proteolytic proc-
ess is one pathway to restrict the cell cycle (35). It is obvious
that the Ub-like domain of RAD23 is responsible both for UV
damage response (4) and to interact with 26 S proteasome in
yeast (33). From the strong conservation in structure and func-
tion of yeast and human repair factors, it is likely that the
Ub-like sequence of hHR23 proteins is also responsible for UV
damage response in mammalian cells via the proteolytic
pathway.
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